Form: S-8

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

October 1, 2024

Documents

Exhibit 107

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Benitec Biopharma Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

               

Security

Type

  

Security

Class

Title

  

Fee

Calculation

Rule

  

Amount

Registered(1)

  

Proposed

Maximum

Offering

Price Per

Share(2)

  

Maximum

Aggregate

Offering

Price(2)

  

Fee

Rate

  

Amount of

Registration

Fee
               
Equity  

Common Stock, par

value $0.0001 per share

   457(a) and 457(h)(2)   7,000,000   $8.98   $62,860,000  

0.0001531

   $9,623.87
       
Total Offering Amounts       $62,860,000
       
Total Fee Offsets       — 
       
Net Fee Due           $9,623.87

 

(1)

Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, (the “Securities Act”) this Registration Statement shall also cover any additional shares of the Company’s common stock that become issuable under the plans set forth herein by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of the Company’s common stock, as applicable.

(2)

Estimated in accordance with Rules 457(c) and (h) solely for the purpose of calculating the registration fee on the basis of $8.98 per share, the average of the high and low prices of the Company’s common stock as reported on The Nasdaq Capital Market on September 27, 2024, a date that is within five business days prior to the date on which this Registration Statement is being filed.